NeuroPace makes the RNS System, an implanted brain device that treats seizures in people with epilepsy. It last closed at $8.20 on Nov 17, up 2.89% on the day. NPCE last reported earnings on Thu, Nov 12, 2026. The average 12-month price target from 6 analysts is $11.00 (+34.1% from the last close), with a high of $14.00 and a low of $7.00. Analyst consensus is Buy, based on the latest ratings from 6 firms (4 buy, 2 hold, 0 sell).
Each firm's latest rating on NPCE in the past 90 days
Average 12-month target
$11.00
▲ 34.1% upside
Based on 6 analysts who set a price target on NPCE in the past 90 days. The average target is $11.00, with a high of $14.00 and a low of $7.00, compared with the last close of $8.20.
Low $7.00Avg $11.00High $14.00
Blue marker: last close $8.20
Highest target$14.00
Average target$11.00
Lowest target$7.00
Latest rating changes
MizuhoTarget lowered
Nov 16Buy$22 → $12
HC Wainwright & Co.Target lowered
Nov 16Buy$20 → $12
Cantor FitzgeraldMaintained
Nov 16Buy$12
JP MorganDowngrade
Nov 13Hold$9
KeybancTarget lowered
Nov 13Buy$18 → $14
Date
Firm
Action
Rating
Price target
Nov 16
Mizuho
Target lowered
Buy
$22 → $12
Nov 16
HC Wainwright & Co.
Target lowered
Buy
$20 → $12
Nov 16
Cantor Fitzgerald
Maintained
Buy
$12
Nov 13
JP Morgan
Downgrade
Hold
$9
Nov 13
Keybanc
Target lowered
Buy
$18 → $14
Loading…
Technical Analysis
NPCE · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 47% below its 20 day and 58% below its 50 day average. It is 79% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 26), oversold. The nearest support is the Pivot S1 at $7.71, and the nearest resistance the Pivot R1 at $8.68.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 13.3%/day
Key levels
$19.6052 week high+139.0%
$14.69200 day average+79.1%
$14.01100 day average+70.9%
$13.27Swing high (Oct 13)+61.8%
$12.9450 day average+57.8%
$12.0320 day average+46.7%
$8.68Pivot R1+5.9%
$8.20Pivot+0.0%
$8.20Last close
$7.71Pivot S1−6.0%
$5.4752 week low−33.3%
Indicators
RSI (14)
26.46
Oversold below 30
Oversold
MACD
-1.05
Below its signal line
Bearish
Stochastic
28.8
Middle of its range
Neutral
ADX (14)
20.1
Weak trend
Williams %R
-67.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
-193.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−33.4%
Change over 10 sessions
Bearish
ATR (14)
$1.09
Typical daily range, 13.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityNormal, 24.4%/day
Key levels
$19.6052 week high+139.0%
$14.69200 day average+79.1%
$14.01100 day average+70.9%
$13.27Swing high (Oct 13)+61.8%
$12.9450 day average+57.8%
$12.0320 day average+46.7%
$8.68Pivot R1+5.9%
$8.20Pivot+0.0%
$8.20Last close
$7.71Pivot S1−6.0%
$5.4752 week low−33.3%
Indicators
RSI (14)
29.87
Oversold below 30
Oversold
MACD
-1.38
Below its signal line
Bearish
Stochastic
20.6
Middle of its range
Neutral
ADX (14)
20.0
No clear trend
Williams %R
-72.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
-250.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−41.6%
Change over 10 sessions
Bearish
ATR (14)
$2.00
Typical daily range, 24.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for NPCE
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how NPCE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow NPCE usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How NPCE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NPCE is in one of them and how their past NPCE trades turned out.
NeuroPace makes medical devices for people with epilepsy, focusing on those whose seizures are not controlled by medication. Its main product is the RNS System, an implant that monitors the brain's electrical activity and delivers small electrical pulses when it detects a seizure starting. The devices are sold mainly to epileptologists and neurosurgeons who treat patients at specialized epilepsy centers in the United States. The company is based in Mountain View, California.